Our customers say Excellent
4.8 out of 5 based on 9701 reviews
  • WHO report finds no risks to public health or abuse potential of CBD

    WHO report finds no risks to public health or abuse potential of CBD
    A report by the World Health Organization (WHO) has found no health-damaging consequences, despite CBD's US federal policy, but several medical uses for cannabidiol, also known as CBD.

    According to a preliminary WHO report published last month, naturally occurring CBD in humans (and animals) is safe, well-tolerated and does not interfere with public health.

    Experts also explained that CBD, a non-psychoactive chemical found in cannabis, does not cause physical dependence and "is not associated with abuse potential". The WHO also wrote that people, unlike THC, can not get high on CBD.

    "To date, there is no evidence for the use of CBD in leisure time or for public health issues related to the use of pure CBD," they write. In fact, evidence suggests that CBD mitigates the effects of THC (whether happy or panicky), according to this and other reports.

    The authors pointed out that the research has officially confirmed some positive effects of the chemical.

    The WHO team noted that CBD has been "shown to be effective in treating epilepsy in adults, children and even animals," and that there is "preliminary evidence" that CBD is used in the treatment of Alzheimer's disease, cancer, psychosis, Parkinson's disease could be useful. and other serious conditions.

    Recognizing this type of discovery in recent years, the report continued, "Several countries have changed their national controls to include CBD as a medicine."

    But the US, the report says, is not one of them. As a cannabis component, CBD remains as a substance controlled by Plan I, meaning that it has a "high abuse potential" in the Federal Government's view. Nevertheless, the "unauthorized medical use" of CBD is quite common, experts found.

    While CBD itself is safe and useful to many users, industry experts have warned that not all cannabis extracts are made the same, pure or with the same extraction methods.

    As the non-profit organization NORML reports for cannabis, WHO is currently considering changing the place of the CBD on its own drug schedule. In September, NORML issued a written statement to the US Food and Drug Administration (FDA) opposing the adoption of international restrictions on CBD access.

    The FDA, which has repeatedly refused to update its position on cannabis products despite a large and growing body of evidence on this issue, is one of several agencies that will advise WHO on its final review of CBD.